These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14586480)

  • 41. Stem cell factor and high-dose twice daily filgrastim is an effective strategy for peripheral blood stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine: results of a Phase II study with an historical comparator.
    Herbert KE; Morgan S; Prince HM; Westerman DA; Wolf MM; Carney DA; Yuen K; di Iulio J; Seymour JF
    Leukemia; 2009 Feb; 23(2):305-12. PubMed ID: 18987661
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Collection of peripheral blood progenitor cells for autografting with low-dose cyclophosphamide plus granulocyte colony-stimulating factor.
    Bellido M; Sureda A; Martino R; Madoz P; García J; Brunet S
    Haematologica; 1998 May; 83(5):428-31. PubMed ID: 9658727
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients with Richter syndrome or fludarabine-refractory chronic lymphocytic leukemia.
    Tsimberidou AM; Kantarjian HM; Cortes J; Thomas DA; Faderl S; Garcia-Manero G; Verstovsek S; Ferrajoli A; Wierda W; Alvarado Y; O'Brien SM; Albitar M; Keating MJ; Giles FJ
    Cancer; 2003 Apr; 97(7):1711-20. PubMed ID: 12655528
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mobilization of peripheral blood progenitor cells by high-dose Ara C, VP-16 and recombinant human granulocyte colony-stimulating factor: factors affecting progenitor cell yields.
    Shimazaki C; Yamagata N; Tatsumi T; Hirata T; Oku N; Ashihara E; Goto H; Inaba T; Fujita N; Haruyama H
    Bone Marrow Transplant; 1995 May; 15(5):763-7. PubMed ID: 7545490
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high-dose cyclophosphamide plus GM-CSF vs G-CSF alone.
    Alegre A; Tomás JF; Martínez-Chamorro C; Gil-Fernández JJ; Fernández-Villalta MJ; Arranz R; Díaz MA; Granda A; Bernardo MR; Escudero A; López-Lorenzo JL; Fernández-Rañada JM
    Bone Marrow Transplant; 1997 Aug; 20(3):211-7. PubMed ID: 9257889
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peripheral blood stem cell (PBSC) mobilization with chemotherapy followed by sequential IL-3 and G-CSF administration in extensively pretreated patients.
    Kolbe K; Peschel C; Rupilius B; Després D; Burger K; Sklenar I; Färber L; Huber C; Derigs HG
    Bone Marrow Transplant; 1997 Dec; 20(12):1027-32. PubMed ID: 9466274
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Difficult stem cell mobilization despite adequate CD34+ cell dose predicts shortened progression free and overall survival after autologous HSCT for lymphoma.
    Tomblyn M; Burns LJ; Blazar B; Wagner J; Lee C; Rogers T; McGlave P; Miller JS; Weisdorf DJ
    Bone Marrow Transplant; 2007 Jul; 40(2):111-8. PubMed ID: 17530003
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of G-CSF on the in vitro cytotoxicity of cytarabine and fludarabine in the FLAG combination in pediatric acute myeloid leukemia.
    Hubeek I; Litvinova E; Peters GJ; Broekhuizen R; Haarman EG; Huismans DR; Cloos J; Zwaan CM; Fleischhack G; Creutzig U; Kaspers GJ
    Int J Oncol; 2004 Dec; 25(6):1823-9. PubMed ID: 15547723
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of intermediate-dose cytarabine on mobilization of peripheral blood hematopoietic stem cell in acute myeloid leukemia].
    Xie M; Zhang Y; Dai M; Wei Q; Li X; Wei Y; Huang F; Fan Z; Jiang Q; Liu Q; Sun J; Feng R
    Zhonghua Xue Ye Xue Za Zhi; 2014 Jul; 35(7):587-91. PubMed ID: 25052597
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer.
    Burns LJ; Weisdorf DJ; DeFor TE; Repka TL; Ogle KM; Hummer C; Miller JS
    Exp Hematol; 2000 Jan; 28(1):96-103. PubMed ID: 10658681
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intermediate-dose Ara-C plus G-CSF for stem cell mobilization in patients with lymphoid malignancies, including predicted poor mobilizers.
    Giebel S; Kruzel T; Czerw T; Sadus-Wojciechowska M; Najda J; Chmielowska E; Grosicki S; Jurczyszyn A; Pasiarski M; Nowara E; Glowala-Kosinka M; Chwieduk A; Mitrus I; Smagur A; Holowiecki J
    Bone Marrow Transplant; 2013 Jul; 48(7):915-21. PubMed ID: 23292239
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Higher efficacy of intermediate dose cytarabine + G-CSF compared to cyclophosphamide + G-CSF in hematopoietic stem cell mobilization in patients with multiple myeloma.
    Bogucka-Fedorczuk A; Czyz A; Kalicińska E; Sawicki M; Laszkowska-Lewko M; Wicherska-Pawłowska K; Rybka J; Szeremet A; Prajs I; Szymczak D; Wróbel T
    J Clin Apher; 2020 Aug; 35(4):246-254. PubMed ID: 32298020
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effect of FLAG consolidation therapy on mobilization of autologous peripheral blood stem cells in patients with acute myelogenous leukemia].
    Li Q; Hong M; Qian SX; Zhang R; Sheng WY; Wu HX; Lu H; Qiu HX; Xu W; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1335-8. PubMed ID: 19840478
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intense reversal of bone marrow angiogenesis after sequential fludarabine-induction and alemtuzumab-consolidation therapy in advanced chronic lymphocytic leukemia.
    Molica S; Montillo M; Ribatti D; Mirabelli R; Tedeschi A; Ricci F; Veronese S; Vacca A; Morra E
    Haematologica; 2007 Oct; 92(10):1367-74. PubMed ID: 17768114
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased efficacy of intermediate-dose cytarabine + G-CSF compared to DHAP + G-CSF for stem cell mobilization in patients with lymphoma: an analysis by the polish lymphoma research group.
    Giebel S; Sadus-Wojciechowska M; Halaburda K; Drozd-Sokolowska J; Wierzbowska A; Najda J; Mendrek W; Sobczyk-Kruszelnicka M; Nowicki M; Holowiecki J; Czerw T
    Ann Hematol; 2016 Jan; 95(2):263-9. PubMed ID: 26611854
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Simultaneous administration of G-CSF and GM-CSF for re-mobilization in patients with inadequate initial progenitor cell collections for autologous transplantation.
    Bashey A; Corringham S; Gilpin E; Fields KK; Smilee RC; DeFrancisco C; Santos-Ada O; Holman P; Carrier E; Ho AD; Lane TA; Ball ED; Janssen WE; Law P
    Cytotherapy; 2000; 2(3):195-200. PubMed ID: 12042042
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-risk fludarabine-pretreated B-cell chronic lymphocytic leukemia's high response rate following sequential DHAP and alemtuzumab administration though in absence of molecular remission.
    Majolino I; Ladetto M; Locasciulli A; Drandi D; Benedetti F; Gallamini A; Chisesi T; De Blasio A; Boccadoro M; Tarella C
    Med Oncol; 2006; 23(3):359-68. PubMed ID: 17018893
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of marrow and blood haemopoietic progenitors in chronic lymphocytic leukaemia before and after chemotherapy.
    Sala R; Mauro FR; Bellucci R; De Propris MS; Cordone I; Lisci A; Foà R; de Fabritiis P
    Eur J Haematol; 1998 Jul; 61(1):14-20. PubMed ID: 9688287
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Peripheral blood stem cell (PBSC) mobilization and transplantation after fludarabine therapy in chronic lymphocytic leukaemia (CLL): a report of the European Blood and Marrow Transplantation (EBMT) CLL subcommittee on behalf of the EBMT Chronic Leukaemias Working Party (CLWP).
    Michallet M; Thiébaut A; Dreger P; Remes K; Milpied N; Santini G; Hamon M; Björkstrand B; Kimby E; Belhabri A; Tanguy ML; Apperley JF
    Br J Haematol; 2000 Mar; 108(3):595-601. PubMed ID: 10759719
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vivo purging with rituximab prior to collection of stem cells for autologous transplantation in chronic lymphocytic leukemia.
    Berkahn L; Simpson D; Raptis A; Klingemann HG
    J Hematother Stem Cell Res; 2002 Apr; 11(2):315-20. PubMed ID: 11983102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.